Acknowledgements

Thank You

The staff at CBCS wish to thank each and every researcher who has become a part of the CBCS extended study family. As you prepare to publish, please include either or both of the following acknowledgments in your manuscript as directed by the CBCS Steering Committee.

Statement of Ethics

The study was approved by the University of North Carolina Institutional Review Board in accordance with U.S. Common Rule. All study participants provided written informed consent prior to study entry. This study complied with relevant ethical regulations, including the Declaration of Helsinki.

CBCS Standard Acknowledgement

This research was supported by a grant from UNC Lineberger Comprehensive Cancer Center, which is funded by the University Cancer Research Fund of North Carolina, the Susan G Komen Foundation (OGUNC1202, OG22873776, SAC210102, TREND21686258), National Cancer Institute (R01CA253450), the National Cancer Institute Specialized Program of Research Excellence (SPORE) in Breast Cancer (NIH/NCI P50-CA058223), the Breast Cancer Research Foundation (HEI-23-003), and the US Department of Defense (HT94252310235). This research recruited participants &/or obtained data with the assistance of Rapid Case Ascertainment, a collaboration between the North Carolina Central Cancer Registry and UNC Lineberger. RCA is supported by a grant from the National Cancer Institute of the National Institutes of Health (P30CA016086). The findings and conclusions in this [presentation or publication] are those of the author(s) and do not necessarily represent the views of the North Carolina Department of Health and Human Services, Division of Public Health. Nucleic acid extractions and/or sample processing and storage were performed by the University of North Carolina BioSpecimen Processing Facility (RRID: SCR_021290 ; https://bsp.web.unc.edu), supported in part by NCI Cancer Center Support Grant 5P30CA016086-46 and the NIEHS UNC Center for Environmental Health and Susceptibility Center grant 5P30ES010126. The authors would like to acknowledge the Breast Cancer Research Foundation HEI-23-003. We are grateful to CBCS participants and study staff.

CBCS Conflict of Interest Acknowledgement

To be used only when PAM50 Gene Expression Data has been included in your shared data set.

The University of North Carolina, Chapel Hill has a license of intellectual property interest in GeneCentric Diagnostics and BioClassifier, LLC, which may be used in this study. The University of North Carolina, Chapel Hill may benefit from this interest that is/are related to this research. The terms of this arrangement have been reviewed and approved by the University of North Carolina, Chapel Hill Conflict of Interest Program in accordance with its conflict of interest policies.

Lisa A. Carey is on the Scientific Advisory Board of the Breast Cancer Research Foundation.

INSIGHT Acknowledgement

To be used only when data from the INSIGHT Study has been included in your shared data set.
This research was funded, in part, by the Advanced Research Projects Agency for Health (ARPA-H) under contract 140D042490008. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S. Government.